Viewing StudyNCT00110695



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00110695
Status: COMPLETED
Last Update Posted: 2010-03-26
First Post: 2005-05-12

Brief Title: Therapy With Abraxane and 5-Fluorouracil Epirubicin Cyclophosphamide FEC for Patients With Breast Cancer
Sponsor: NSABP Foundation Inc
Organization: NSABP Foundation Inc

Organization Data

Organization: NSABP Foundation Inc
Class: NETWORK
Study ID: NSABP FB-AX-003
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: NSABP Foundation Inc
Lead Sponsor Class: NETWORK
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: Norman Wolmark MD
Old Organization: NSABP Foundation Inc

Collaborators

Name Class
Celgene Corporation INDUSTRY